![[logo] US EPA](../gif/logo_epaseal.gif){kind=logo}
Index of Cleared Science Reviews for Cyproconazole (Pc Code 128993)
You will need Adobe Reader to view some of the files on this page. See EPA's PDF page
December 05, 1988. DER. 5 Page(s).
Henry Nelson. Envirnomental Fate & Ground Water Branch.
Study 3 Metabolism - Aerobic Soil (162-1). Pages 5-8 removed, registrant data.
MRID 40607708.
Document (PDF) (252 KB PDF).
December 05, 1988. DER. 6 Page(s).
H. Nelson. Environmental Fate & Ground Water Branch.
Study 5; Field Dissipation - Terrestrial (164-1). MRID 00406077.
Document (PDF) (219 KB PDF).
December 05, 1988. DER. 7 Page(s).
H. Nelson. Environmental Fate & Ground Water Branch.
Study 6; Field Dissipation - Terrestrial (164-1). MRID 40624301.
Document (PDF) (284 KB PDF).
January 16, 1989. Memorandum. 248 Page(s).
K. Clark Swentzel. Toxicology Branch 2.
Cyproconazole Technical and Cyproconazole 40 WG: Evaluation of Toxicity Data
Submitted to Support Registration for Non- Food Uses. MRID 406069-05 thru 09,
406077-14 thru 17, 406077-20, 23 thru 29, 406243-04 thru 07. Tox review 007003.
Document (PDF) (8703 KB PDF).
Attachment(s) Following:
January 16, 1989. Memorandum.
K. Clark Swentzel. Toxicology Branch 2.
(continued) Pages 12-19 removed, draft label. Pages 30-32, 36-37, 42-46, 64, 75,
90, 100-102, 112-131, 141-156, 158-164, 187, 193-194, 207-208, 212-214, 218-219,
223-227, 231-232, 238-248 removed, registrant data.
*End of Attachments*
January 17, 1989. Memorandum. 19 Page(s).
K. Clark Swentzel. Toxicology Branch 2.
Cyproconazole Technical and Cyproconazole 40 WG: Evaluation of Toxicity Data
Submitted to Support Registration for Non- food Uses. 55947-RGG, 55947-RGE
Pages 12-19 removed-draft label.
Document (PDF) (670 KB PDF).
June 29, 1989. Memorandum. 2 Page(s).
K. Clark Swentzel. Toxicology Branch II.
Cyproconazole (SAN 619F) WG 40: Requested Waiver for the Requirement of a 21-Day
Dermal Toxicity Study 55947-RGE. Tox review 007282.
Document (PDF) (107 KB PDF).
June 29, 1989. Memorandum. 2 Page(s).
K. Clark Swentzel. Toxicology Branch II.
Cyproconazole: Response to the Evaluation of an In Vivo Mouse Micronucleus Assay
(Accession no. 406077-28; Laboratory Project ID 249.215.005). Tox review 007283.
Document (PDF) (81 KB PDF).
July 11, 1989. Memorandum. 7 Page(s).
K. Clark Swentzel. Toxicology Branch II.
Cyproconazole Technical: Second Primary Eye Irritation Study 55947-RGG.
Tox review 007325. Pages 4-6 removed-registrant data.
Document (PDF) (186 KB PDF).
December 01, 1989. Memorandum. 20 Page(s).
K. Clark Swentzel. Toxicology Branch II.
Cyproconazole - In Vitro Chromosome Assay with Chinese Hamster Ovary (CHO)
Cells Pages 12-13, 15-16, 18-20 removed, registrant data. 55947-RGG.
MRID 411587-01. Tox review 007632.
Document (PDF) (787 KB PDF).
February 05, 1990. Memorandum. 3 Page(s).
K. Clark Swentzel. Toxicology Branch II.
Cyproconazole-Supplemental Data for a Developmental Toxicity Study in Rats
55947-RGG. Tox review 007730.
Document (PDF) (225 KB PDF).
February 26, 1990. Memorandum. 2 Page(s).
K. Clark Swentzel. Toxicology Branch II.
Cyproconazole 40 WG. Waiver request for an acute inhalation study. 55947-RGE.
Document (PDF) (85 KB PDF).
February 28, 1990. Memorandum. 6 Page(s).
Linda Taylor. Toxicology Branch II.
Cyproconazole - Draft Protocol for a Dermal Penetration Study 55947-RGG.
Document (PDF) (434 KB PDF).
April 10, 1990. Data Eval. Rec. 24 Page(s).
Robert Weir. Dynamac Corporation.
Chronic Toxicity/Oncogenicity Feeding Study in Rats Tox review 007871.
MRID 411647-01.
Document (PDF) (1081 KB PDF).
April 23, 1990. Memorandum. 16 Page(s).
Linda Taylor. Toxicology Branch II.
Cyproconazole - Dog Chronic Feeding Study and Rat Chronic Feeding/Oncogenicity
Studies 55947-RGG. Tox review 007871. MRID 412129-01, 411647-01.
Pages 14-16 removed-registrant data.
Document (PDF) (803 KB PDF).
May 07, 1990. Memorandum. 4 Page(s).
Jess Rowland. Toxicology Branch II.
Cyproconazole (SAN619F): Request by Sandoz Crop Protection Corporation to Establish
a NOEL in a 13- week Feeding Study in Rats and to Accept the Study for Regulatory Purposes.
Tox review 007907. MRID 406077-18.
Document (PDF) (189 KB PDF).
May 07, 1990. Memorandum. 7 Page(s).
Jess Rowland. Toxicology Branch II.
Cyproconazole (SAN 619F): Review of Compound Stability Data and Sampling Techniques in Response
to EPA Evaluation of a 2-Generation Rat Reproduction Study with SAN 619 F Technical
Tox review 007908. MRID 412945-00.
Document (PDF) (279 KB PDF).
May 29, 1990. Memorandum. 9 Page(s).
Bernice Fisher. Science Analysis & Coordination Branch.
Cyproconazole(SAN 619F)- Qualitative Risk Assessment, Mouse (CD-1) Study.
Tox review 008014.
Document (PDF) (302 KB PDF).
June 07, 1990. Data Eval. Rec. 24 Page(s).
Robert Weir. Dynamac Corporation.
Oncogenicity Feeding Study in Mice (Guideline 83-2). MRID 411472-01.
Document (PDF) (1070 KB PDF).
June 14, 1990. Memorandum. 172 Page(s).
Esther Rinde. Health Effects Division.
Peer review of Cyproconazole.
Pages 81-82, 84-85, 87-89, 101-103, 165-167 removed, registrant data.
Document (PDF) (8185 KB PDF).
June 20, 1990. Memorandum. 2 Page(s).
Kerry Dearfield. Science Analysis & Coordination Branch.
Additional Mutagenicity Study for Cyproconazole.
Document (PDF) (126 KB PDF).
June 27, 1990. Memorandum. 2 Page(s).
K. Clark Swentzel. Toxicology Branch II.
Cyproconazole - Mouse Carcinogenicity Study 55947-RGG
MRID 411472-01. Tox review 008009.
Document (PDF) (103 KB PDF).
September 26, 1990. Memorandum. 15 Page(s).
Patricia McLaughlin. Toxicology Branch II.
Peer Review of Cyproconazole. Tox review 008352.
Document (PDF) (807 KB PDF).
October 16, 1990. Memorandum. 5 Page(s).
K. Clark Swentzel. Toxicology Branch II.
Cyproconazole 40 WG. Waiver request for an acute inhalation study 55947-RGE.
Pages 3-5 removed-registrant data.
Document (PDF) (145 KB PDF).
October 17, 1990. Memorandum. 14 Page(s).
Linda Taylor. Toxicology Branch II.
Cyproconazole - Rat Metabolism Study In Support of Coffee Import Tolerance Petition
MRID 415349-01. PP# 0E3875. Tox review 008129.
Pages 8-13 removed-registrant data.
Document (PDF) (437 KB PDF).
December 03, 1990. Memorandum. 2 Page(s).
Karen Whitby. Toxicology Branch II.
Cyproconazole - Supplemental Data for a Developmental Toxicity Study in Rats.
MRID No. 416526-00.
Document (PDF) (72 KB PDF).
June 27, 1991. Memorandum. 27 Page(s).
Akiva Abramovitch. Environmental Fate & Ground Water Branch.
Review aerobic soil metabolism study and company's response to adsorption/desorption review.
MRID Nos. 41441301, and 41474401.
Pages 8-21 deleted - registration data.
Document (PDF) (579 KB PDF).
August 21, 1991. Memorandum. 21 Page(s).
Esther Rinde. Health Effects Division.
Second Carcinogenicity Peer Review Meeting on Cyproconazole.
Document (PDF) (1316 KB PDF).
August 29, 1991. Memorandum. 57 Page(s).
Akiva Abramovitch. Environmental Fate & Ground Water Branch.
Review Terrestrial Field Dissipation Studies for support of turf use.
MRID Nos. 41384101, 41384102, 41461501, 41800701, 41800702, and 41384105.
Pages 10-11, 15-22, 25-31, 34-40, 43-50, and 53-57 deleted - registration data.
Document (PDF) (1353 KB PDF).
April 29, 1992. Memorandum. 12 Page(s).
Linda Taylor. Toxicology Branch II.
Second Carcinogenicity Peer Review of Cyproconazole.
Document (PDF) (571 KB PDF).
May 14, 1992. Memorandum. 2 Page(s).
Bernice Fisher. Science Analysis & Coordination Branch.
Cyproconazole, Quantitative Risk Assessment, CD-1 Mouse Dietary Study.
Document (PDF) (99 KB PDF).
June 18, 1992. Memorandum. 2 Page(s).
Bernice Fisher. Science Analysis & Coordination Branch.
Cyproconazole, Revised Quantitative Risk Assessment, CD-1 Mouse Dietary Study.
Document (PDF) (109 KB PDF).
September 21, 1992. Memorandum. 3 Page(s).
Reto Engler. Health Effects Division.
Cyproconazole: Is a Repeat Rat Study Needed for a Carcinogenicity Risk Assessment?.
Document (PDF) (205 KB PDF).
December 04, 1992. Memorandum. 5 Page(s).
Linda Taylor. Toxicology Branch II.
Cyproconazole (Third Meeting):
Reclassification from a Group C with Quantitation to a Group B2 Carcinogen.
Document (PDF) (311 KB PDF).
March 01, 1993. Memorandum. 42 Page(s).
Akiva Abramovitch. Environmental Fate & Ground Water Branch.
Review bareground terrestrial field dissipation studies for new chemical registration.
MRID Nos. 42430701 & 42489702. Guideline 164-1.
Pages 10-23 and 27-36 deleted - registration data.
Document (PDF) (948 KB PDF).
June 11, 1993. Memorandum. 27 Page(s).
Akiva Abramovitch. Environmental Fate & Ground Water Branch.
Purpose: To review ancillary aerobic soil metabolism data. MRID 42534801 S.
Guideline 162-1. Pages 8-27 removed-registrant data.
Document (PDF) (371 KB PDF).
July 09, 1993. MEMORANDUM. 2 Page(s).
Linda Taylor. Toxicology Branch.
Cyproconazole: Pathology Report Summary of 13-Week Feeding Study in Rats - Marked 6(a)(2).
MRID 427449-00 & 01.
Document (PDF) (93 KB PDF).
August 17, 1993. Memorandum. 7 Page(s).
George Ghali. Health Effects Division.
RfD/ Peer Review Report of Cyproconazole.
Document (PDF) (415 KB PDF).
March 30, 1994. Memorandum. 20 Page(s).
Linda Taylor. Toxicology Branch.
Cyproconazole: 13-Week Feeding Study in Rats Marked 6(a)(2).
MRID 430786-01.Tox Review #010879.
Document (PDF) (1629 KB PDF).
April 12, 1995. Memorandum. 4 Page(s).
Linda Taylor. Toxicology Branch.
Cyproconazole: 13-Week Feeding Study in Rats Registrant's Response to TB II Review End of February 1999.
Document (PDF) (331 KB PDF).
June 16, 2005. Memorandum. 1 Page.
Jenna Carter. Science Information & Analysis Branch.
Usage Report in Support of Reregistration for the Fungicide Triazoles: Metconazole
(125619), Paclobutrazol (125601), Prothioconazole (113961), Bromuconazole (120503),
Triticonazole (125620), Cyproconazole (128993), Difenoconazole (128847), Triadimenol….
Document (PDF) (51 KB PDF).